MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    NIH funds Gut-Brain Parkinson’s Disease Consortium

    C. Goetz, L. Becker, A. Bharucha, E. Chang, A. Keshavarzian, B. Kuo, K. Newby, K. Poston, L. Sanders, R. Savica, A. Sharma, A. Videnovic, L. Wruck, T. Xie (Chicago, USA)

    Objective: Describe the National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) multicenter (UO1) Consortium on PD Gut-Brain Communication. Background: A 2024 Notice of Funding…
  • 2025 International Congress

    Advancements in Microbiome Research: Total Microbial Load, Differential Absolute Abundance, and Correlations with Immune Transcriptomics

    B. Palushaj, M. Chakraborty, I. Porter, G. Reynolds, E. Brooks, Z. He, A. Bhatt, K. Poston (Palo Alto, USA)

    Objective: Quantify total microbial load in the gut microbiome of people with Parkinson’s disease (PD) and compare the absolute abundance of bacterial taxa between PD…
  • 2025 International Congress

    Does the cerebellum compensate to enable motor learning in Parkinson’s Disease?

    PC. Iyer, BE. Fisher (Los Angeles, USA)

    Objective: To test the causal relation between cerebellar function and learning in PD. Background: Neuroimaging studies reveal that people with Parkinson’s disease (PwPD) exhibit increased…
  • 2025 International Congress

    Coping with Parkinson’s Disease through the Lens of Personality Systems Interactions (PSI) Theory: Two Case Studies

    E. Wünnenberg, N. Baumann (Trier, Germany)

    Objective: This study examines how concepts from motivation and personality research contribute to understanding coping strategies in individuals with Parkinson’s disease (PD). Background: Effective treatment…
  • 2025 International Congress

    Cognitive Load Modulates Excitability of Subthalamic Motor Circuitry in Parkinson’s Disease

    V. Zapata, G. Marin, D. Parra, J. Ailsworth, J. Cordoba, E. Chen, M. Lowe, S. Jones, B. Walter, R. Rammo, S. Nagel, A. Machado, K. Baker, D. Escobar (Cleveland, USA)

    Objective: To characterize the effect of cognitive load on the excitability of circuitry connected with the subthalamic nucleus (STN) motor territory in Parkinson’s disease (PD)…
  • 2025 International Congress

    GBA Mutations Alter Subthalamic and Nigral Neural Activity in Parkinson’s Disease

    N. Pozzi, I. Hanafi, F. Kremer, T. Musacchio, M. Reich, C. Palmisano, I. Isaias, J. Volkmann, M. Muthuraman, P. Capetian (Würzburg, Germany)

    Objective: To investigate the neurophysiological basis of Parkinson’s disease (PD) in patients with glucocerebrosidase (GBA) mutations. Background: Alterations in subthalamic neural activity are associated with…
  • 2025 International Congress

    Solengepras: An Investigational Therapy with Potential Benefits on Functional and Non-Motor Measures in Parkinson’s Disease (PD)

    S. Isaacson, K. Chou, H. Sarva, S. Merchant, C. Scholl, M. Charles, N. Brice, L. Dawson, M. Carlton, S. Vaidya, K. Kieburtz, R. Hauser, A. Ellenbogen (Ann Arbor, USA)

    Objective: Solengepras is a GPR6-inhibitor that is being studied as an investigational treatment for Parkinson’s Disease (PD). Background: GPR6 is a novel G-protein-coupled receptor found…
  • 2025 International Congress

    Long-term effects of a periodic intensive rehabilitation program in People with Parkinson’s Disease

    Y. Yamaguchi, J. Ogawa, K. Kakegawa, M. Matsuda (Ginza, Chuo-ku, Japan)

    Objective: This study aimed to examine the long-term effects of a periodic intensive rehabilitation program incorporating tele-tools on the progression of motor symptoms in people…
  • 2025 International Congress

    Exploring Clinical and Neurophysiologic Predictors of Adaptive Deep Brain Stimulation Response in Parkinson’s disease

    T. Herrington, M. Beudel, J. Ostrem, S. Little, A. Ramirez-Zamora, L. Almeida, A. Fasano, T. Hassell, K. Mitchell, E. Moro, M. Gostkowski, N. Sarangmat, L. Tonder, Y. Tan, R. Summers, S. Stanslaski, H. Bronte-Stewart (San Francisco, USA)

    Objective: To evaluate clinical and neurophysiologic characteristics that may predict a positive clinical response to adaptive deep brain stimulation (aDBS) in patients previously stable on…
  • 2025 International Congress

    Methodological considerations supporting a time-to-event primary endpoint in the PADOVA study in early-stage Parkinson’s disease participants on stable symptomatic treatment

    N. Pross, G. Pagano, D. Trundell, J. Anzures-Cabrera, T. Simuni, K. Marek, N. Pavese, K. Seppi, F. Stocchi, R. Postuma, A. Monnet, L. Rutten-Jacobs, G. Respondek, L. Boak, G. Kerchner, P. Brundin, H. Svoboda, T. Nikolcheva, A. Bonni (Basel, Switzerland)

    Objective: To provide the methodological rationale for using a time-to-event (TTE) primary endpoint in the PADOVA study. Background: The use of symptomatic medications represents a…
  • « Previous Page
  • 1
  • …
  • 297
  • 298
  • 299
  • 300
  • 301
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley